Thursday, March 26, 2020

Aurobindo Pharma gets EIR for Hyderabad facility by USFDA

The Company has received the Establishment Inspection Report (EIR) with Voluntary Action Initiated (VAl) status from USFDA.

from India Infoline News Service https://ift.tt/3ao3Yvo
Posted by at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)